SC-35LD Research Specimens (5x100mg) – Toronto
These SC-35LD Toronto capsules provide standardized 100mg units for controlled clinical research across the Greater Toronto Area. The 5-capsule set (500mg total) enables:
Toronto Research Applications:
– Dose-response studies at UofT’s Department of Pharmacology
– Psychedelic-assisted therapy protocols (CAMH-approved)
– Bioavailability comparisons with other formulations
Key Features:
– Precision Dosing: 100mg ±2mg variance (Toronto lab verified)
– Delayed-Release: Vegetable capsules for consistent absorption
– Batch Tracking: Lot #TCR-SC35-2024 with full documentation
Academic Partnerships:
1. Centre for Addiction and Mental Health depression trials
2. Women’s College Hospital PTSD research
3. Ontario College of Art & Design sensory studies
Local Utilization:
Currently employed in:
– Downtown Toronto psychiatric clinics
– North York university psychology departments
– Mississauga wellness research programs
Storage Protocols:
– Blister-packed with oxygen absorbers
– Stable for 18 months at 15-20°C (Toronto lab standards)
– Includes humidity indicator cards
Complete Documentation:
– HPLC purity report (99.1% minimum)
– Residual solvent analysis
– Chain of custody records
Available only to Section 56-exempt researchers. Not for human consumption.
